Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-28

Clinical Trial Update: Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ursodeoxycholic acid plus budesonide versus ursodeoxycholic acid alone in primary biliary cirrhosis; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide (BUDESONIDE)
  • Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Primary Biliary Cirrhosis | Phase 3 | Status: TERMINATED